Cyanvac
0 followers
Cyanvac develops vaccines using a proprietary transformational parainfluenza virus 5 (PIV5)-based vector.
Org chart
Fred C. Davison
Chief Executive Officer
Collapse
Gary Titus
Chief Financial Officer
Hong Jin
Chief Scientific Officer
Marinka Tellier
Chief Regulatory Affairs Officer
Samuel Wu
Chief Business Officer
Teams
This company has no teams yet